Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Risk parity assigns capital to balance risk contributions across asset classes in retirement portfolios, aiming for steadier, more resilient returns.
26,821 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
A top Deutsche Bank economist warns that AI’s productivity gains may take years to materialize. If returns lag, risin...
AscendEX ceased normal operations on July 1 as MiCA rules tightened, with withdrawal requests slowed or blocked. Zach...
A licensing scam involving money orders shows how a state worker altered payees, affecting nail technician applicants...
When a Planet Labs CEO sells shares, investors take note. This article breaks down what the move could signal, how to...
Bunkerhill Health has secured $55 million to expand its AI agents inside hospitals, aiming to cut wait times, reduce ...
Air-taxi darlings Joby, Archer, and EHang have fallen sharply in 2026 as cert timelines and cash burn loom large. Inv...
ServiceNow could deliver durable growth as organizations automate more workflows. This article lays out the bull case...
A small AI-focused player claims it helps customers turn modest marketing spend into impressive gains. This piece bre...
Bitcoin remains range-bound under pressure around the $55,000 mark as on-chain metrics flag weak demand. Analysts say...
As remitly gears up for 2025, investors should focus on growth drivers, margin potential, and the risks that could sh...
As Alphabet treads into 2026, three driving forces could shape its trajectory: AI-powered growth, smarter ads monetiz...